RBM15-mediated m6A modification in cancer progression and tumor immunity: molecular mechanisms and therapeutic potential

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis shows RBM15 regulates tumor immunology and cellular mechanisms, indicating its role as a biomarker for cancer therapy.

Tumor immunity is influenced by RBM15, altering immune responses and leading to immune evasion.
Key mechanisms involve cellular processes like splicing and metabolic reprogramming in cancer cells.
Assessment reveals the potential of RBM15 as a therapeutic target in cancer treatment.
Findings suggest RBM15 may serve as a valuable biomarker for predicting cancer prognosis and therapy outcomes.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Observational analysis shows RBM15 regulates tumor immunology and cellular mechanisms, indicating its role as a biomarker for cancer therapy.